Department of Orthopaedics, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan 610500, China.
Biomed Res Int. 2020 Aug 10;2020:4637109. doi: 10.1155/2020/4637109. eCollection 2020.
In recent years, the mechanism of cancer research has become hotspots of life science and medicine, especially due to the rapid development of molecular medicine and bioinformatics research. Similarly, the molecular mechanism also has received increasing attention in osteosarcoma (OS) research. Also, a considerable amount of research confirmed that circular RNAs (circRNAs) could regulate cancer cell growth and metastasis. This study aimed to explore the effect of a circRNA, circCCDC66, on OS and reveal its potential molecular mechanism. High circCCDC66 expression level was found in OS patient-derived tissue samples and OS cell lines by qRT-PCR. The abilities cell proliferation and metastatic of U2OS and SW1353 cells were then assessed by Cell Counting Kit-8 and transwell assay, respectively. The interaction between circCCDC66 and its target miRNAs were verified by the dual-luciferase reporter assay. Through functional experiments, we found that circCCDC66 knockdown promoted the inhibition of cell proliferation and metastatic of OS cell lines. From mechanistic perspective, circCCDC66 upregulated PTP1B by sponging miR-338-3p. Collectively, our findings demonstrated that circCCDC66 contributed to malignant behaviors of OS cells by miR-338-3p/PTP1B pathway, which suggested circCCDC66/miR-338-3p/PTP1B axis might be a potential therapeutic target.
近年来,癌症研究的机制已成为生命科学和医学的热点,尤其是由于分子医学和生物信息学研究的快速发展。同样,分子机制在骨肉瘤(OS)研究中也受到了越来越多的关注。此外,大量研究证实环状 RNA(circRNA)可以调节癌细胞的生长和转移。本研究旨在探讨环状 RNA circCCDC66 对 OS 的影响,并揭示其潜在的分子机制。通过 qRT-PCR 发现,circCCDC66 在 OS 患者来源的组织样本和 OS 细胞系中高表达。然后通过细胞计数试剂盒-8 和 Transwell 测定分别评估 U2OS 和 SW1353 细胞的增殖和转移能力。通过双荧光素酶报告基因测定验证了 circCCDC66 与其靶 miRNAs 之间的相互作用。通过功能实验,我们发现 circCCDC66 敲低促进了 OS 细胞系中细胞增殖和转移的抑制。从机制上讲,circCCDC66 通过海绵吸附 miR-338-3p 上调了 PTP1B。总之,我们的研究结果表明,circCCDC66 通过 miR-338-3p/PTP1B 通路促进 OS 细胞的恶性行为,提示 circCCDC66/miR-338-3p/PTP1B 轴可能是一个潜在的治疗靶点。